Læknablaðið - 15.04.2008, Síða 42

FRÆÐIGREINAR
LUNGNAKRABBAMEIN
35. Guðmundsdóttir A, Reynisson K, Guðmundsson G.
Lungnaástungur meðhjálp tölvusneiðmynda á Landspítala.
Ábendingar, fylgikvillar og útkoma. Læknablaðið 2005; 91:
917-21.
36. Kinoshita F, Kato T, Sugiura K, et al. CT-guided trans-
thoracic needle biopsy using a puncture site-down
positioning technique. AJR Am J Roentgenol 2006; 187:
926-32.
37. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer
statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
38. Mountain CF. Revisions in the Intemational System for
Staging Lung Cancer. Chest 1997; 111:1710-7.
39. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA, Jr. Early
detection of lung cancer: clinical perspectives of recent
advances in biology and radiology. Clin Cancer Res 2001; 7:
5-22.
40. Fontana RS. The Mayo Lung Project: a perspective. Cancer
2000; 89 (11 Suppl): 2352-5.
41. Tockman MS. Survival and mortality from lung cancer in a
screened population: The Johns Hopkins Study. Chest 1986;
89: 324S-325S.
42. Schwartz AM, Henson DE. Diagnostic surgical pathology
in lung cancer: ACCP evidence-based clinical practice
guidelines (2nd edition). Chest 2007; 132(3 Suppl): 78S-93S.
43. Kaneko M, Kusumoto M, Kobayashi T, et al. Computed
tomography screening for lung carcinoma in Japan. Cancer
2000; 89(11 Suppl): 2485-8.
44. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW,
Smith JP, Miettinen OS. Survival of patients with stage I
lung cancer detected on CT screening. N Engl J Med 2006;
355:1763-71.
45. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer
screening. N Engl J Med 2005; 352: 2714-20.
46. Elliott JA, Osterlind K, Hirsch FR, Hansen HH. Metastatic
patterns in small-cell lung cancer: correlation of autopsy
findings with clinical parameters in 537 patients. J Clin
Oncol 1987; 5: 246-54.
47. Lassen U, Osterlind K, Hansen M, Dombernowsky P,
Bergman B, Hansen HH. Long-term survival in small-
cell lung cancer: posttreatment characteristics in patients
surviving 5 to 18+ years—an analysis of 1,714 consecutive
patients. J Clin Oncol 1995; 13:1215-20.
48. Singh S, Parulekar W, Murray N, Feld R, Evans WK, Tu D,
et al. Influence of sex on toxicity and treatment outcome in
small-cell lung cancer. J Clin Oncol 2005;23(4):850-6.
49. Spira A, Ettinger DS. Multidisciplinary management of
lung cancer. N Engl J Med 2004;350(4):379-92.
50. Myrdal G. Lung cancer. Epidemiological an clinical studies
with special reference to surgical treatment. Uppsala:
Uppsala University; 2003.
51. Mery CM, Pappas AN, Burt BM, et al. Diameter of non-
small cell lung cancer correlates with long-term survival:
implications for T stage. Chest 2005; 128: 3255-60.
52. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and
survival in resected lung carcinoma based on the new
intemational staging system. J Thorac Cardiovasc Surg
1988; 96: 440-7.
53. Gail MH, Eagan RT, Feld R, et al. Prognostic factors in
patients with resected stage I non-small cell lung cancer. A
report from the Lung Cancer Study Group. Cancer 1984; 54:
1802-13.
54. Kwiatkowski DJ, Harpole DH, Jr., Godleski J, et al.
Molecular pathologic substaging in 244 stage I non-small-
cell lung cancer patients: clinical implications. J Clin Oncol
1998; 16: 2468-77.
55. Pater JL, Loeb M. Nonanatomic prognostic factors in
carcinoma of the lung: a multivariate analysis. Cancer 1982;
50: 326-31.
56. Munden RF, Swisher SS, Stevens CW, Stewart DJ. Imaging
of the patient with non-small cell lung cancer. Radiology
2005; 237: 803-18.
57. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus
tumors: CT and MR imaging. Radiology 1989; 170(3 Pt 1):
637-41.
58. Schreiber G, McCrory DC. Performance characteristics of
different modalities for diagnosis of suspected lung cancer:
summary of published evidence. Chest 2003; 123(1 Suppl):
115S-128S.
59. Chhajed PN, Bemasconi M, Gambazzi F, et al. Combining
bronchoscopy and positron emission tomography for the
diagnosis of the small pulmonary nodule < or = 3 cm. Chest
2005; 128: 3558-64.
60. Laroche C, Fairbaim I, Moss H, et al. Role of computed
tomographic scanning of the thorax prior to bronchoscopy
in the investigation of suspected lung cancer. Thorax 2000;
55: 359-63.
61. Makris D, Scherpereel A, Leroy S, et al. Electromagnetic
navigation diagnostic bronchoscopy for small peripheral
lung lesions. Eur Respir J 2007; 29:1187-92.
62. Kurimoto N, Miyazawa T, Okimasa S, et al. Endobronchial
ultrasonography using a guide sheath increases the ability
to diagnose peripheral pulmonary lesions endoscopically.
Chest 2004; 126: 959-65.
63. Namke T, Tsuchiya R, Kondo H, Nakayama H, Asamura
H. Lymph node sampling in lung cancer: how should it be
done? Eur J Cardiothorac Surg 1999; 16 Suppl 1: S17-24.
64. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines
for preoperative lymph node staging for non-small cell
lung cancer. Eur J Cardiothorac Surg 2007; 32:1-8.
65. De Leyn P, Vansteenkiste J, Cuypers P, et al. Role of cervical
mediastinoscopy in staging of non-small cell lung cancer
without enlarged mediastinal lymph nodes on CT scan. Eur
J Cardiothorac Surg 1997; 12: 706-12.
66. Toloza EM, Harpole L, McCrory DC. Noninvasive staging
of non-small cell lung cancer: a review of the current
evidence. Chest 2003; 123(1 Suppl): 137S-146S.
67. Devaraj A, Cook GJ, Hansell DM. PET/CT in non-small cell
lung cancer staging-promises and problems. Clin Radiol
2007; 62: 97-108.
68. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness
of positron emission tomography in the preoperative
assessment of patients with suspected non-small-cell lung
cancer: the PLUS multicentre randomised trial. Lancet
2002; 359:1388-93.
69. Annema JT, Versteegh MI, Veselic M, Voigt P, Rabe KF.
Endoscopic ultrasound-guided fine-needle aspiration in
the diagnosis and staging of lung cancer and its impact on
surgical staging. J Clin Oncol 2005; 23: 8357-61.
70. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of
endobronchial ultrasound, positron emission tomography,
and CT for lymph node staging of lung cancer. Chest 2006;
130: 710-8.
71. Rintoul RC, Skwarski KM, Murchison JT, Hill A,
Walker WS, Penman ID. Endoscopic and endobronchial
ultrasound real-time fine-needle aspiration for staging of
the mediastinum in lung cancer. Chest 2004; 126: 2020-2.
72. Cerfolio RJ, Bryant AS, Eloubeidi MA. Accessing the
aortopulmonary window (#5) and the paraaortic (#6)
lymph nodes in patients with non-small cell lung cancer.
Ann Thorac Surg 2007; 84: 940-5.
73. Detterbeck FC, DeCamp MM, Jr., Kohman LJ, Silvestri GA.
Lung cancer. Invasive staging: the guidelines. Chest 2003;
123(1 Suppl): 167S-175S.
74. Cerfolio RJ, Bryant AS. Distribution and likelihood of
lymph node metastasis based on the lobar location of
nonsmall-cell lung cancer. Ann Thorac Surg 2006; 81:1969-
73; discussion 1973.
75. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J,
Silvestri GA. Invasive mediastinal staging of lung cancer:
ACCP evidence-based clinical practice guidelines (2nd
edition). Chest 2007; 132(3 Suppl): 202S-220S.
76. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive
staging of non-small cell lung cancer: a review of the
current evidence. Chest 2003; 123(1 Suppl): 157S-166S.
77. Park BJ, Flores R, Downey RJ, Bains MS, Rusch VW.
Managementofmajorhemorrhageduringmediastinoscopy.
J Thorac Cardiovasc Surg 2003; 126: 726-31.
78. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive
staging of non-small cell lung cancer: ACCP evidenced-
based clinical practice guidelines (2nd edition). Chest 2007;
132(3 Suppl): 178S-201S.
79. Fischer BM, Mortensen J. The future in diagnosis and
staging of lung cancer: positron emission tomography.
Respiration 2006; 73: 267-76.
80. Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.
Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose
positron emission tomography in the evaluation of bony
metastases in lung cancer. Mol Imaging Biol 2003; 5: 26-31.
81. Reif MS, Socinski MA, Rivera MP. Evidence-based
medicine in the treatment of non-small-cell lung cancer.
Clin Chest Med 2000; 21:107-20, ix.
82. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K.
Treatment of non-small cell lung cancer stage I and stage
II: ACCP evidence-based clinical practice guidelines (2nd
edition). Chest 2007; 132(3 Suppl): 234S-242S.
83. Nesbitt JC, Putnam JB, Jr., Walsh GL, Roth JA, Mountain
CF. Survival in early-stage non-small cell lung cancer. Ann
Thorac Surg 1995; 60(2): 466-72.
84. Damhuis RA, Schutte PR. Resection rates and postoperative
mortality in 7,899 patients with lung cancer. Eur Respir J
1996; 9: 7-10.
310 LÆKNAblaðið 2008/94